PURA - Puration US Patented Cannabis Extract Goes Into New Beverage Line Produced By Alkame Holdings
May 30 2017 - 11:51AM
InvestorsHub NewsWire
Dallas, TX – May 30, 2017
– InvestorsHub NewsWire -- Puration, Inc (USOTC: PURA) today
announced its U.S. Patented Cannabis Extract will be infused into a
new beverage. The beverage is being produced by Alkame
Holdings, Inc. (USOTC: ALKM). North American Cannabis
Holdings, Inc. (USOTC: USMJ) last week announced plans to launch
the AmeriCanna Cafe CBD Infused Bottled Water at the upcoming
Southwest Cannabis Conference and Expo, June 9-11,
in Miami with Special Guest and cannabis advocate, the
Emmy Award winning talk show host, Montel
Williams. The AmeriCanna Café CBD Infused
Bottled Water will include CBD extracted by PURA.
CBD Infused Water Backed By Two U.S. Patents
The AmeriCanna Cafe CBD Infused Water is backed the technology of
two U.S. Patents – one from PURA and one form ALKM. The CBD is
extracted through a U.S. Patented cannabis extraction process
licensed by PURA from NCM BioTech. The Patented process produces
CBD with the highest purity avoiding the residual containments
found from extraction solvents that contaminate other CBDs.
The CBD is blended with water treated by a second U.S. Patented
process, owend by ALKM, to create a premium oxygenated alkaline
water, with natural antioxidants, that tastes great and offers more
benefits than regular water. The Patented water treatment
process, proven through a double-blind placebo, peer-backed
research, has shown it can boost the immune system and physical
performance. It is the only hydration water patented for high
levels of stabilized dissolved oxygen to increase aerobic capacity
and improve performance. The water is a powerful source of
natural antioxidants which boost the immune system, and provide
antioxidant protection.
To learn more about Puration,
visit:
purationinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024